In VitroExposure of Leukocytes to HIV Preexposure Prophylaxis Decreases Mitochondrial Function and Alters Gene Expression Profiles

Abstract

Background: The use of antiretroviral therapy (ART) as pre-exposure prophylaxis (PrEP) is an effective strategy for preventing HIV acquisition. The cellular consequences of PrEP exposure, however, have not been sufficiently explored to determine potential effects on health in individuals without HIV. Methods: Peripheral blood mononuclear cells (PBMCs) from people without HIV were exposed to tenofovir disoproxil fumarate (TDF) or emtricitabine (FTC) overnight. Mitochondrial mass and function were measured by flow cytometry and Agilent XFp analyzer. Monocyte-derived macrophages (MDMs) were differentiated in 20% autologous serum for 5 days in the presence or absence of TDF or FTC, and surface markers, lipid uptake, and efferocytosis were measured by flow cytometry. MDM gene expression was measured using RNAseq. Plasma lipids were measured using mass spectrometry. Results: PBMCs exposed to TDF or FTC had decreased maximal oxygen consumption rate (OCR) and reduced mitochondrial mass. Exposure to PrEP also increased reactive oxygen species (ROS) production from monocyte subsets. Compared to MDMs cultured in medium alone, cells differentiated in the presence of TDF (829 genes) or FTC (888) genes had significant changes in gene expression. Further, PrEP-exposed MDMs had decreased mitochondrial mass, and displayed increased lipid uptake and reduced efferocytosis. Plasma biomarkers and lipid levels were also altered in vivo in individuals receiving a PrEP regimen. Conclusions: Exposure of leukocytes to TDF or FTC resulted in decreased mitochondrial function, and altered functional and transcriptional profiles. These findings may have important implications for the metabolic and immunologic consequences of PrEP in populations at risk for HIV acquisition.

Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection

“…Furthermore, they show that CD4 T-cells treated with dolutegravir and elvitegravir shift the cytokine response of these cells from a polyfunctional one to a TNF-α dominated one ( 119 ). A similar observation was made by Bowman and colleagues, which demonstrate that human macrophages exposed to tenofovir disoproxil fumarate and emtricitabine have lower mitochondrial mass and increased lipid uptake ( 120 ). These studies can help explain the observations made by Correa-Macedo et al.…”

The Impact of HIV- and ART-Induced Mitochondrial Dysfunction in Cellular Senescence and Aging

“…PBMCs from individuals treated with PrEP showed reduced cellular respiration and mitochondrial mass. Additionally, monocyte-derived macrophages from PrEP-treated individuals exhibited increased production of ROS and decreased mitochondrial mass, further implicating ART in inducing mitochondrial dysfunction even in the absence of HIV infection [ 167 ]. This is of particular importance considering the target populations that are not HIV-infected but have an increased predisposition to HIV, including individuals using PrEP as well as children of infected mothers receiving PrEP as part of prevention of mother to child transmission programs.…”

Role of RIPK1 in SMAC mimetics-induced apoptosis in primary human HIV-infected macrophages

“…The high variability in SM-mediated killing of ex vivo generated MDMs from monocytes of ART-treated and naïve untreated groups may also be due to the myeloid population in the patients which is exposed to a variety of inflammatory/anti-inflammatory cytokines and exposure to a variety of opportunistic infections 56 . Exposure to ARV drugs may be somewhat toxic to these cells and affect their ability to respond to stress by altering their mitochondrial function 57 , 58 .…”